Workflow
德展健康(000813) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥192,816,625.91, a decrease of 8.87% compared to ¥211,589,350.75 in the same period last year[5]. - Net profit attributable to shareholders was ¥30,445,095.31, down 52.56% from ¥64,181,873.34 year-on-year[5]. - The company reported a net profit of ¥22,929,114.75 for the period, down 60.46% from ¥57,996,391.95 in the previous year[11]. - Basic and diluted earnings per share were both ¥0.0136, reflecting a decline of 52.61% from ¥0.0287 in the same period last year[5]. - Total operating revenue for the first quarter was ¥192,816,625.91, a decrease of 8.9% compared to ¥211,589,350.75 in the previous year[27]. - Net profit for the period was ¥22,929,114.75, down 60.5% from ¥57,996,391.95 in the same period last year[30]. - The total comprehensive income attributable to shareholders of the parent company was ¥30,445,095.31, down from ¥64,181,873.34 in the previous year[32]. Cash Flow - The net cash flow from operating activities decreased by 15.33%, amounting to ¥130,435,562.96 compared to ¥154,051,928.33 in the previous year[5]. - The cash inflow from operating activities totaled $299,649,594.13, a decrease of 29.4% compared to $423,978,066.95 in the previous period[34]. - The cash outflow from operating activities was $169,214,031.17, down 37.4% from $269,926,138.62 in the prior period[37]. - The net cash flow from operating activities was $130,435,562.96, a decline of 15.3% compared to $154,051,928.33 in the previous period[37]. - Cash inflow from investment activities was $80,551,396.03, significantly lower than $196,122,174.13 in the prior period, representing a decrease of 59.0%[37]. - The net cash flow from investment activities was -$15,445,078.29, compared to -$186,375,668.19 in the previous period, indicating an improvement[37]. - The company received $80,000,000.00 from the recovery of investments, down from $186,390,596.64 in the prior period, a decrease of 57.0%[37]. - The total cash outflow for investment activities was $95,996,474.32, down 75.1% from $382,497,842.32 in the previous period[37]. - The company reported a cash inflow of $98,881,175.84 from other operating activities, a significant increase from $13,111,086.01 in the previous period[34]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,854,779,624.68, an increase of 1.33% from ¥5,778,043,347.05 at the end of the previous year[5]. - The total assets of the company at the end of the reporting period amount to 5,854,779,624.68 yuan, an increase from 5,778,043,347.05 yuan at the beginning of the year[20]. - The company's cash and cash equivalents stand at 1,592,533,545.20 yuan, up from 1,473,720,797.44 yuan at the beginning of the year[20]. - The company's total current assets are reported at 4,056,672,615.21 yuan, compared to 3,562,755,881.68 yuan at the start of the year, indicating a growth of approximately 13.87%[20]. - The company has reduced its inventory from 300,017,175.21 yuan to 270,122,398.21 yuan, reflecting a decrease of about 9.93%[20]. - The company has a total of 457,366,466.97 yuan in long-term equity investments, slightly down from 459,617,483.71 yuan at the beginning of the year[20]. - The company’s total non-current assets decreased from 2,215,287,465.37 yuan to 1,798,107,009.47 yuan, a decline of approximately 18.75%[20]. - Total liabilities increased to ¥361,822,032.91, up from ¥308,053,292.52 year-over-year[26]. - Total equity attributable to shareholders of the parent company was ¥5,402,595,666.16, slightly up from ¥5,372,112,148.36[26]. Research and Development - The company's R&D expenses for Q1 2022 were ¥10,715,438.38, a decrease of 43.00% compared to ¥18,800,084.65 in the same period last year[8]. - Research and development expenses for the quarter were ¥10,715,438.38, down from ¥18,800,084.65 in the previous year[27]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 50,534, with the top ten shareholders holding significant stakes[12]. - Meilin Holdings Group holds 20.08% of shares, amounting to 448,263,156 shares, while Shanghai Yueye Equity Investment Management Partnership holds 18.55% with 414,138,066 shares[12]. Other Information - The company recorded a total of ¥1,092,360.73 in non-recurring gains and losses for the period[7]. - The company completed the repurchase and cancellation of 6,693,668 restricted shares, accounting for 0.30% of the total share capital before the repurchase[16]. - The company reported a financial asset impairment loss of ¥10,691,394.68 during the quarter[30]. - The company did not conduct an audit for the first quarter report[40].